10 Best Stocks to Buy Right Now According to AI
The US economy is navigating a complex and difficult environment defined by decelerating growth, persistent inflationary shocks, and a shifting consumer landscape.
Harmony Biosciences Holdings Inc. (HRMY)
Market is closed
Sector: Healthcare
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Armistice Capital Steven Boyd | 1,624,000 | $45,488,240 | +225% | 0.81% |
| 2. | Arrowstreet Capital Peter Rathjens, Bruce Clarke And John Campbell | 1,382,113 | $38,712,985 | -8% | 0.02% |
| 3. | Renaissance Technologies Jim Simons | 1,077,371 | $30,177,162 | +1% | 0.05% |
| 4. | Millennium Management Israel Englander | 954,359 | $26,731,596 | +312% | 0.01% |
| 5. | Two Sigma Advisors John Overdeck And David Siegel | 733,443 | $20,543,738 | +603% | 0.02% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $24.00 | 339,476 | $8,147,424.00 | 10,651,120 | 2020-08-21 | Filing | |
| $34.30 | 3,922 | $134,524.60 | 42,702 | 2020-08-26 | Filing | |
| $34.20 | 823 | $28,146.60 | 38,780 | 2020-08-25 | Filing | |
| $24.00 | 132,503 | $3,180,072.00 | 4,409,803 | 2020-08-21 | Filing | |
| $34.30 | 3,057 | $104,855.10 | 37,957 | 2020-08-24 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $37.15 | 3,746 | $139,171.39 | 24,521 | 2026-01-26 | Filing | |
| $35.92 | 20,961 | $752,833.18 | 0 | 2026-01-15 | Filing | |
| $40.11 | 5,933 | $237,956.61 | 0 | 2025-12-12 | Filing | |
| $40.11 | 20,000 | $802,146.00 | 0 | 2025-12-12 | Filing | |
| $39.54 | 20,000 | $790,896.00 | 0 | 2025-12-05 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 7,070,035 | $198,031,682 | 0% | |
| 2. | 3,157,639 | $88,445,461 | 0% | |
| 3. | 2,714,353 | $76,029,028 | 0% | |
| 4. | 2,105,179 | $58,966,064 | 0.03% | |
| 5. | 2,102,315 | $58,885,843 | 0% |
News See All
Harmony Biosciences Holdings (HRMY) Announces Financial Results for Q1 2026
Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) is one of the best healthcare stocks to buy for the long term. Harmony Biosciences Holdings, Inc.
10 Best Healthcare Stocks to Buy for the Long Term
On May 7, Haig Bathgate, CEO of Callanish Capital, appeared on CNCB to talk about his bullish view on the global markets amid the Iran war, and how its impact would be short-lived, especially when compared...
10 Best Small-Cap Value Stocks to Buy
Small-cap stocks are the real thing in an equity market under immense pressure amid geopolitical and monetary policy uncertainties.
Deutsche Bank Cuts PT on Harmony Biosciences Holdings (HRMY) to $30 From $31
Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) is one of the best cheap biotech stocks to buy now. On February 25, Deutsche Bank adjusted the price target on Harmony Biosciences Holdings, Inc.
12 Cheap Biotech Stocks to Buy Now
On February 27, Eli Casdin, Casdin Capital CEO, appeared on CNBC’s ‘Closing Bell’ to talk about the biotech sector.
Truist Securities Downgrades Harmony Biosciences Holdings, Inc. (HRMY) to Hold After Patent Trial Developments
TheFly reported on February 20 that Truist Securities downgraded HRMY from Buy to Hold following the conclusion of its bench trial against Paragraph IV filer AET Pharma. The analyst pointed out that...
20 Best Investments in 2026
The S&P 500 reached a new high as investors focused on upcoming tech sector earnings, and U.S. markets reportedly recovered in the last week of January amid heightened geopolitical concerns.
Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) Q4 2025 Earnings Call Transcript
Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) Q4 2025 Earnings Call Transcript February 24, 2026Harmony Biosciences Holdings, Inc. misses on earnings expectations.
Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) Q3 2025 Earnings Call Transcript
Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) Q3 2025 Earnings Call Transcript November 4, 2025Harmony Biosciences Holdings, Inc. misses on earnings expectations.
Hedge Fund Resource Center